Picture of 111 logo

YI 111 Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Momentum

Relative Strength (%)
1m-22.54%
3m-33.77%
6m-64.27%
1yr-70.1%
Volume Change (%)
10d/3m+42.7%
Price vs... (%)
52w High-68.45%
50d MA-25.43%
200d MA-51.38%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)3.14
PEG Ratio (f)0.05
EPS Growth (f)142.3%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Valuen/a
Price to Tang. Bookn/a
Price to Free Cashflown/a
Price to Sales0.04
EV to EBITDAn/a

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-66.3%
Return on Equityn/a
Operating Margin-1.68%

Financial Summary

Year End 31st DecUnit201820192020202120222023E2024ECAGR / Avg
Total RevenueCNYm1,785.973,952.058,203.1612,425.913,516.719,841.3223,487.8869.73%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/an/an/an/an/a+142.3n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of 111 EPS forecast chart

Profile Summary

111, Inc. is a China-based Internet medical and health company. The Company is mainly engaged in the provision of online medical services, drug purchasing and health management services through Internet and information technology. The Company mainly conducts its business in the domestic market.

Directors

    Last Annual
    December 31st, 2022
    Last Interim
    September 30th, 2023
    Incorporated
    January 1st, 1970
    Public Since
    September 12th, 2018
    No. of Employees
    1,657
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    us flag iconNASDAQ Global Market
    Shares in Issue
    167,986,482
    Blurred out image of a map
    Address
    3-4/F, SHANGHAI, 201203
    Web
    http://gangling.111.com.cn/
    Phone
    +86 2120536666
    Auditors
    Deloitte Touche Tohmatsu Certified Public Accountants LLP

    YI Share Price Performance

    Upcoming Events for YI

    Q1 2024 111 Inc Earnings Release

    Q2 2024 111 Inc Earnings Release

    Similar to YI

    Picture of ADMA Biologics logo

    ADMA Biologics

    us flag iconNASDAQ Global Market

    Picture of Alimera Sciences logo

    Alimera Sciences

    us flag iconNASDAQ Global Market

    Picture of ANI Pharmaceuticals logo

    ANI Pharmaceuticals

    us flag iconNASDAQ Global Market

    Picture of Aquestive Therapeutics logo

    Aquestive Therapeutics

    us flag iconNASDAQ Global Market

    Picture of Avadel Pharmaceuticals logo

    Avadel Pharmaceuticals

    us flag iconNASDAQ Global Market

    FAQ